Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Vaccine). Showing records 1 – 30 of 1632 total matches.

[1] [2] [3] [4] [5] … [55]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


California State Polytechnic University – Pomona

1. Rubio, Jennifer. Efficacy Against Vaginal Herpes Virus Infection Using Adjuvants in a gD Tripeptide Liposomal Vaccine.

Degree: MS, Biological Sciences, 2018, California State Polytechnic University – Pomona

 Infections caused by Herpes Simplex 2 (HSV-2) manifest as painful, genital lesions with frequent recurrent episodes that cannot be cured by antiviral drug therapy, underscoring… (more)

Subjects/Keywords: vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rubio, J. (2018). Efficacy Against Vaginal Herpes Virus Infection Using Adjuvants in a gD Tripeptide Liposomal Vaccine. (Masters Thesis). California State Polytechnic University – Pomona. Retrieved from http://hdl.handle.net/10211.3/199941

Chicago Manual of Style (16th Edition):

Rubio, Jennifer. “Efficacy Against Vaginal Herpes Virus Infection Using Adjuvants in a gD Tripeptide Liposomal Vaccine.” 2018. Masters Thesis, California State Polytechnic University – Pomona. Accessed June 17, 2019. http://hdl.handle.net/10211.3/199941.

MLA Handbook (7th Edition):

Rubio, Jennifer. “Efficacy Against Vaginal Herpes Virus Infection Using Adjuvants in a gD Tripeptide Liposomal Vaccine.” 2018. Web. 17 Jun 2019.

Vancouver:

Rubio J. Efficacy Against Vaginal Herpes Virus Infection Using Adjuvants in a gD Tripeptide Liposomal Vaccine. [Internet] [Masters thesis]. California State Polytechnic University – Pomona; 2018. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10211.3/199941.

Council of Science Editors:

Rubio J. Efficacy Against Vaginal Herpes Virus Infection Using Adjuvants in a gD Tripeptide Liposomal Vaccine. [Masters Thesis]. California State Polytechnic University – Pomona; 2018. Available from: http://hdl.handle.net/10211.3/199941


Université de Neuchâtel

2. Wyss, Jean-Christophe. Identification et caractérisation de protéines antigéniques de 'Borrelia burgdorferi' sensu lato.

Degree: 2012, Université de Neuchâtel

 <i>Borrelia afzelii</i>, <i>B. garinii</i>, et <i>B. burgdorferi</i> sont trois des cinq espèces de <i>Borrelia</i> définitivement reconnues comme responsables de la borréliose de Lyme en Europe.… (more)

Subjects/Keywords: Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wyss, J. (2012). Identification et caractérisation de protéines antigéniques de 'Borrelia burgdorferi' sensu lato. (Thesis). Université de Neuchâtel. Retrieved from http://doc.rero.ch/record/32347

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wyss, Jean-Christophe. “Identification et caractérisation de protéines antigéniques de 'Borrelia burgdorferi' sensu lato.” 2012. Thesis, Université de Neuchâtel. Accessed June 17, 2019. http://doc.rero.ch/record/32347.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wyss, Jean-Christophe. “Identification et caractérisation de protéines antigéniques de 'Borrelia burgdorferi' sensu lato.” 2012. Web. 17 Jun 2019.

Vancouver:

Wyss J. Identification et caractérisation de protéines antigéniques de 'Borrelia burgdorferi' sensu lato. [Internet] [Thesis]. Université de Neuchâtel; 2012. [cited 2019 Jun 17]. Available from: http://doc.rero.ch/record/32347.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wyss J. Identification et caractérisation de protéines antigéniques de 'Borrelia burgdorferi' sensu lato. [Thesis]. Université de Neuchâtel; 2012. Available from: http://doc.rero.ch/record/32347

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

3. Jiz, Mario Antonio II L. Vaccine Development in Schistosomiasis japonica: Paramyosin As a Leading Candidate.

Degree: PhD, Division of Biology and Medicine. Pathobiology, 2009, Brown University

 Schistosomiasis is a chronic debilitating disease caused by helminths of the genus Schistosoma, and currently affecting millions in the developing world. Treatment with Praziquantel has… (more)

Subjects/Keywords: vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jiz, M. A. I. L. (2009). Vaccine Development in Schistosomiasis japonica: Paramyosin As a Leading Candidate. (Doctoral Dissertation). Brown University. Retrieved from https://repository.library.brown.edu/studio/item/bdr:175/

Chicago Manual of Style (16th Edition):

Jiz, Mario Antonio II L. “Vaccine Development in Schistosomiasis japonica: Paramyosin As a Leading Candidate.” 2009. Doctoral Dissertation, Brown University. Accessed June 17, 2019. https://repository.library.brown.edu/studio/item/bdr:175/.

MLA Handbook (7th Edition):

Jiz, Mario Antonio II L. “Vaccine Development in Schistosomiasis japonica: Paramyosin As a Leading Candidate.” 2009. Web. 17 Jun 2019.

Vancouver:

Jiz MAIL. Vaccine Development in Schistosomiasis japonica: Paramyosin As a Leading Candidate. [Internet] [Doctoral dissertation]. Brown University; 2009. [cited 2019 Jun 17]. Available from: https://repository.library.brown.edu/studio/item/bdr:175/.

Council of Science Editors:

Jiz MAIL. Vaccine Development in Schistosomiasis japonica: Paramyosin As a Leading Candidate. [Doctoral Dissertation]. Brown University; 2009. Available from: https://repository.library.brown.edu/studio/item/bdr:175/

4. 後藤, 正志. 癌免疫療法剤評価システムの開発 : Development of cancer immunotherapy medicine evaluation system; ガン メンエキ リョウホウザイ ヒョウカ システム ノ カイハツ.

Degree: Nara Institute of Science and Technology / 奈良先端科学技術大学院大学

Subjects/Keywords: vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

後藤, . (n.d.). 癌免疫療法剤評価システムの開発 : Development of cancer immunotherapy medicine evaluation system; ガン メンエキ リョウホウザイ ヒョウカ システム ノ カイハツ. (Thesis). Nara Institute of Science and Technology / 奈良先端科学技術大学院大学. Retrieved from http://hdl.handle.net/10061/4142

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

後藤, 正志. “癌免疫療法剤評価システムの開発 : Development of cancer immunotherapy medicine evaluation system; ガン メンエキ リョウホウザイ ヒョウカ システム ノ カイハツ.” Thesis, Nara Institute of Science and Technology / 奈良先端科学技術大学院大学. Accessed June 17, 2019. http://hdl.handle.net/10061/4142.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

後藤, 正志. “癌免疫療法剤評価システムの開発 : Development of cancer immunotherapy medicine evaluation system; ガン メンエキ リョウホウザイ ヒョウカ システム ノ カイハツ.” Web. 17 Jun 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

後藤 . 癌免疫療法剤評価システムの開発 : Development of cancer immunotherapy medicine evaluation system; ガン メンエキ リョウホウザイ ヒョウカ システム ノ カイハツ. [Internet] [Thesis]. Nara Institute of Science and Technology / 奈良先端科学技術大学院大学; [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10061/4142.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

後藤 . 癌免疫療法剤評価システムの開発 : Development of cancer immunotherapy medicine evaluation system; ガン メンエキ リョウホウザイ ヒョウカ システム ノ カイハツ. [Thesis]. Nara Institute of Science and Technology / 奈良先端科学技術大学院大学; Available from: http://hdl.handle.net/10061/4142

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Hong Kong

5. Fan, Hiu-yan. Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review.

Degree: MPH, 2014, University of Hong Kong

Background Pneumococcal disease, caused by Streptococcus pneumoniae (S. pneumoniae), leads to a great burden of morbidity and mortality globally, especially in developing countries. World Health… (more)

Subjects/Keywords: Pneumococcal vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fan, H. (2014). Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review. (Masters Thesis). University of Hong Kong. Retrieved from Fan, H. [樊曉欣]. (2014). Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320300 ; http://dx.doi.org/10.5353/th_b5320300 ; http://hdl.handle.net/10722/206903

Chicago Manual of Style (16th Edition):

Fan, Hiu-yan. “Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review.” 2014. Masters Thesis, University of Hong Kong. Accessed June 17, 2019. Fan, H. [樊曉欣]. (2014). Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320300 ; http://dx.doi.org/10.5353/th_b5320300 ; http://hdl.handle.net/10722/206903.

MLA Handbook (7th Edition):

Fan, Hiu-yan. “Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review.” 2014. Web. 17 Jun 2019.

Vancouver:

Fan H. Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review. [Internet] [Masters thesis]. University of Hong Kong; 2014. [cited 2019 Jun 17]. Available from: Fan, H. [樊曉欣]. (2014). Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320300 ; http://dx.doi.org/10.5353/th_b5320300 ; http://hdl.handle.net/10722/206903.

Council of Science Editors:

Fan H. Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review. [Masters Thesis]. University of Hong Kong; 2014. Available from: Fan, H. [樊曉欣]. (2014). Economic evaluation of the second generation pneumococcal conjugate vaccine in children : a systematic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320300 ; http://dx.doi.org/10.5353/th_b5320300 ; http://hdl.handle.net/10722/206903


University of Hong Kong

6. Leung, May-bo, Mabel. The cost effectiveness of varicella vaccination program : a systemic review.

Degree: MPH, 2014, University of Hong Kong

Background Chickenpox is a common infectious disease among children. Ever since a live attenuated vaccine was developed in 1970s, different countries have adopted different vaccination… (more)

Subjects/Keywords: Chickenpox vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leung, May-bo, M. (2014). The cost effectiveness of varicella vaccination program : a systemic review. (Masters Thesis). University of Hong Kong. Retrieved from Leung, M. M. [梁美寶]. (2014). The cost effectiveness of varicella vaccination program : a systemic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320441 ; http://dx.doi.org/10.5353/th_b5320441 ; http://hdl.handle.net/10722/206948

Chicago Manual of Style (16th Edition):

Leung, May-bo, Mabel. “The cost effectiveness of varicella vaccination program : a systemic review.” 2014. Masters Thesis, University of Hong Kong. Accessed June 17, 2019. Leung, M. M. [梁美寶]. (2014). The cost effectiveness of varicella vaccination program : a systemic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320441 ; http://dx.doi.org/10.5353/th_b5320441 ; http://hdl.handle.net/10722/206948.

MLA Handbook (7th Edition):

Leung, May-bo, Mabel. “The cost effectiveness of varicella vaccination program : a systemic review.” 2014. Web. 17 Jun 2019.

Vancouver:

Leung, May-bo M. The cost effectiveness of varicella vaccination program : a systemic review. [Internet] [Masters thesis]. University of Hong Kong; 2014. [cited 2019 Jun 17]. Available from: Leung, M. M. [梁美寶]. (2014). The cost effectiveness of varicella vaccination program : a systemic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320441 ; http://dx.doi.org/10.5353/th_b5320441 ; http://hdl.handle.net/10722/206948.

Council of Science Editors:

Leung, May-bo M. The cost effectiveness of varicella vaccination program : a systemic review. [Masters Thesis]. University of Hong Kong; 2014. Available from: Leung, M. M. [梁美寶]. (2014). The cost effectiveness of varicella vaccination program : a systemic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320441 ; http://dx.doi.org/10.5353/th_b5320441 ; http://hdl.handle.net/10722/206948


University of Hong Kong

7. 王筠婷; Wong, Kwan-ting. The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review.

Degree: MPH, 2014, University of Hong Kong

BACKGROUND: Despite the current recommendation by the Centre for Health Protection (CHP)of Hong Kong for adults aged 65 years or above to receive 23-valent pneumococcal… (more)

Subjects/Keywords: Pneumococcal vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

王筠婷; Wong, K. (2014). The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review. (Masters Thesis). University of Hong Kong. Retrieved from Wong, K. [王筠婷]. (2014). The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320733 ; http://dx.doi.org/10.5353/th_b5320733 ; http://hdl.handle.net/10722/206978

Chicago Manual of Style (16th Edition):

王筠婷; Wong, Kwan-ting. “The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review.” 2014. Masters Thesis, University of Hong Kong. Accessed June 17, 2019. Wong, K. [王筠婷]. (2014). The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320733 ; http://dx.doi.org/10.5353/th_b5320733 ; http://hdl.handle.net/10722/206978.

MLA Handbook (7th Edition):

王筠婷; Wong, Kwan-ting. “The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review.” 2014. Web. 17 Jun 2019.

Vancouver:

王筠婷; Wong K. The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review. [Internet] [Masters thesis]. University of Hong Kong; 2014. [cited 2019 Jun 17]. Available from: Wong, K. [王筠婷]. (2014). The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320733 ; http://dx.doi.org/10.5353/th_b5320733 ; http://hdl.handle.net/10722/206978.

Council of Science Editors:

王筠婷; Wong K. The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review. [Masters Thesis]. University of Hong Kong; 2014. Available from: Wong, K. [王筠婷]. (2014). The cost-effectiveness of 13-valent pneumococcal conjugate vaccine for older adults : a systematic review. (Thesis). University of Hong Kong, Pokfulam, Hong Kong SAR. Retrieved from http://dx.doi.org/10.5353/th_b5320733 ; http://dx.doi.org/10.5353/th_b5320733 ; http://hdl.handle.net/10722/206978


Baylor University

8. [No author]. Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform.

Degree: 2016, Baylor University

 Replicative virus-based vaccines provide potential solutions to avoid the natural deficits of traditional single-protein subunit vaccines. Unlike subunit vaccines, the infectious nature of viral particles… (more)

Subjects/Keywords: Virus. Vaccine.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

author], [. (2016). Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform. (Thesis). Baylor University. Retrieved from http://hdl.handle.net/2104/9799

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

author], [No. “Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform. ” 2016. Thesis, Baylor University. Accessed June 17, 2019. http://hdl.handle.net/2104/9799.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

author], [No. “Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform. ” 2016. Web. 17 Jun 2019.

Vancouver:

author] [. Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform. [Internet] [Thesis]. Baylor University; 2016. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/2104/9799.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

author] [. Plant-produced, trans-encapsidated, replicative viral nanoparticles as a vaccine platform. [Thesis]. Baylor University; 2016. Available from: http://hdl.handle.net/2104/9799

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Boston University

9. Alonso, Adrian Miguel. Development of a multiple antigen presenting system (MAPS) vaccine for Group B Streptoccocus.

Degree: MS, Medical Sciences, 2018, Boston University

 BACKGROUND: Group B Streptococcus (GBS) is a Gram-positive bacterium that is a common cause of infection in neonates and is the predominant pathogen causing meningitis… (more)

Subjects/Keywords: Microbiology; Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alonso, A. M. (2018). Development of a multiple antigen presenting system (MAPS) vaccine for Group B Streptoccocus. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/30870

Chicago Manual of Style (16th Edition):

Alonso, Adrian Miguel. “Development of a multiple antigen presenting system (MAPS) vaccine for Group B Streptoccocus.” 2018. Masters Thesis, Boston University. Accessed June 17, 2019. http://hdl.handle.net/2144/30870.

MLA Handbook (7th Edition):

Alonso, Adrian Miguel. “Development of a multiple antigen presenting system (MAPS) vaccine for Group B Streptoccocus.” 2018. Web. 17 Jun 2019.

Vancouver:

Alonso AM. Development of a multiple antigen presenting system (MAPS) vaccine for Group B Streptoccocus. [Internet] [Masters thesis]. Boston University; 2018. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/2144/30870.

Council of Science Editors:

Alonso AM. Development of a multiple antigen presenting system (MAPS) vaccine for Group B Streptoccocus. [Masters Thesis]. Boston University; 2018. Available from: http://hdl.handle.net/2144/30870

10. Delaney, Kristen. A Flagellin-Poxvirus Antigen Vaccine: Strengths and Limitations.

Degree: 2009, Wake Forest University

 Bacterial flagellin is a potent adjuvant that enhances adaptive immune responses to a variety of antigens. The vaccinia virus antigens L1R and B5R are highly… (more)

Subjects/Keywords: vaccine

…flagellin-pox antigen fusion vaccine 48 13 Plasma from immunized mice is capable of… …ABSTRACT Delaney, Kristen N. A FLAGELLIN-POXVIRUS ANTIGEN VACCINE: STRENGTHS AND LIMITATIONS… …can be administered in a single vaccine. x INTRODUCTION Variola Virus Pathogenesis and… …not permitted, vaccinia virus is used as a model agent in poxvirus vaccine studies… …remains infectious. It has been shown that acellular vaccine strategies that target both… 

Page 1 Page 2 Page 3 Page 4 Page 5

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Delaney, K. (2009). A Flagellin-Poxvirus Antigen Vaccine: Strengths and Limitations. (Thesis). Wake Forest University. Retrieved from http://hdl.handle.net/10339/14912

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Delaney, Kristen. “A Flagellin-Poxvirus Antigen Vaccine: Strengths and Limitations.” 2009. Thesis, Wake Forest University. Accessed June 17, 2019. http://hdl.handle.net/10339/14912.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Delaney, Kristen. “A Flagellin-Poxvirus Antigen Vaccine: Strengths and Limitations.” 2009. Web. 17 Jun 2019.

Vancouver:

Delaney K. A Flagellin-Poxvirus Antigen Vaccine: Strengths and Limitations. [Internet] [Thesis]. Wake Forest University; 2009. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10339/14912.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Delaney K. A Flagellin-Poxvirus Antigen Vaccine: Strengths and Limitations. [Thesis]. Wake Forest University; 2009. Available from: http://hdl.handle.net/10339/14912

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. Smedberg, Jason. Determining the Innate and Adaptive Immune Responses to Vesicular Stomatitis Virus Vaccine Vectors.

Degree: 2014, Wake Forest University

 Vesicular stomatitis virus (VSV) vaccine vectors have been engineered to express many different antigens. Studies in mice and nonhuman primates have demonstrated efficacy against several… (more)

Subjects/Keywords: Vaccine

…ABSTRACT Vesicular stomatitis virus (VSV) vaccine vectors have been engineered… …efficacy against several pathogens. A novel strategy to enhance VSV as an effective vaccine is to… …engineer vectors that induce innate immune mechanisms. We have generated an improved VSV vaccine… …prevents the virus from suppressing host responses and the addition of a vaccine adjuvant… …flagellin. VSV is currently in clinical trials as a recombinant vaccine vector against… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Smedberg, J. (2014). Determining the Innate and Adaptive Immune Responses to Vesicular Stomatitis Virus Vaccine Vectors. (Thesis). Wake Forest University. Retrieved from http://hdl.handle.net/10339/39297

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Smedberg, Jason. “Determining the Innate and Adaptive Immune Responses to Vesicular Stomatitis Virus Vaccine Vectors.” 2014. Thesis, Wake Forest University. Accessed June 17, 2019. http://hdl.handle.net/10339/39297.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Smedberg, Jason. “Determining the Innate and Adaptive Immune Responses to Vesicular Stomatitis Virus Vaccine Vectors.” 2014. Web. 17 Jun 2019.

Vancouver:

Smedberg J. Determining the Innate and Adaptive Immune Responses to Vesicular Stomatitis Virus Vaccine Vectors. [Internet] [Thesis]. Wake Forest University; 2014. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10339/39297.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Smedberg J. Determining the Innate and Adaptive Immune Responses to Vesicular Stomatitis Virus Vaccine Vectors. [Thesis]. Wake Forest University; 2014. Available from: http://hdl.handle.net/10339/39297

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

12. Crabtree, Juliet. The Function of PTPN22 and the Autoimmune Risk Variant LypW in Immune Responses to Vaccination.

Degree: PhD, Microbiology, Immunology and Cancer Biology, 2016, University of Minnesota

 High-affinity antibody production, T cell activation, and Interferon upregulation all contribute to protective immunity that occurs in humans following influenza immunization. Hematopoietic cell-specific PTPN22 encodes… (more)

Subjects/Keywords: PTPN22; Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Crabtree, J. (2016). The Function of PTPN22 and the Autoimmune Risk Variant LypW in Immune Responses to Vaccination. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/182251

Chicago Manual of Style (16th Edition):

Crabtree, Juliet. “The Function of PTPN22 and the Autoimmune Risk Variant LypW in Immune Responses to Vaccination.” 2016. Doctoral Dissertation, University of Minnesota. Accessed June 17, 2019. http://hdl.handle.net/11299/182251.

MLA Handbook (7th Edition):

Crabtree, Juliet. “The Function of PTPN22 and the Autoimmune Risk Variant LypW in Immune Responses to Vaccination.” 2016. Web. 17 Jun 2019.

Vancouver:

Crabtree J. The Function of PTPN22 and the Autoimmune Risk Variant LypW in Immune Responses to Vaccination. [Internet] [Doctoral dissertation]. University of Minnesota; 2016. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/11299/182251.

Council of Science Editors:

Crabtree J. The Function of PTPN22 and the Autoimmune Risk Variant LypW in Immune Responses to Vaccination. [Doctoral Dissertation]. University of Minnesota; 2016. Available from: http://hdl.handle.net/11299/182251

13. Bello, Alexander Juanito Arquillano. Linking the tropism and transduction efficiency of porcine-derived adeno-associated viruses to their transgene-mediated protective efficacy.

Degree: Medical Microbiology, 2014, University of Manitoba

 Adeno-associated virus (AAV) is a small, non-pathogenic virus, exploited as a vector for gene therapy applications, with many successful clinical trials. However, these vectors are… (more)

Subjects/Keywords: AAV; Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bello, A. J. A. (2014). Linking the tropism and transduction efficiency of porcine-derived adeno-associated viruses to their transgene-mediated protective efficacy. (Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/23945

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bello, Alexander Juanito Arquillano. “Linking the tropism and transduction efficiency of porcine-derived adeno-associated viruses to their transgene-mediated protective efficacy.” 2014. Thesis, University of Manitoba. Accessed June 17, 2019. http://hdl.handle.net/1993/23945.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bello, Alexander Juanito Arquillano. “Linking the tropism and transduction efficiency of porcine-derived adeno-associated viruses to their transgene-mediated protective efficacy.” 2014. Web. 17 Jun 2019.

Vancouver:

Bello AJA. Linking the tropism and transduction efficiency of porcine-derived adeno-associated viruses to their transgene-mediated protective efficacy. [Internet] [Thesis]. University of Manitoba; 2014. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/1993/23945.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bello AJA. Linking the tropism and transduction efficiency of porcine-derived adeno-associated viruses to their transgene-mediated protective efficacy. [Thesis]. University of Manitoba; 2014. Available from: http://hdl.handle.net/1993/23945

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Georgia State University

14. Arana, Jorge E. Comparison of Post-Licensure Safety Surveillance of 13-Valent Pneumococcal Conjugate Vaccine and 7-Valent Pneumococcal Conjugate Vaccine: Data from the Vaccine Advere Event Reporting System (Vaers).

Degree: MPH, Public Health, 2011, Georgia State University

  Comparison of Post-licensure safety surveillance of 13-Valent Pneumococcal Conjugate vaccine and 7-Valent Pneumococcal Conjugate vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS).… (more)

Subjects/Keywords: Pneumococcal vaccine; vaccine; adverse event; Public Health

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Arana, J. E. (2011). Comparison of Post-Licensure Safety Surveillance of 13-Valent Pneumococcal Conjugate Vaccine and 7-Valent Pneumococcal Conjugate Vaccine: Data from the Vaccine Advere Event Reporting System (Vaers). (Thesis). Georgia State University. Retrieved from https://scholarworks.gsu.edu/iph_theses/159

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Arana, Jorge E. “Comparison of Post-Licensure Safety Surveillance of 13-Valent Pneumococcal Conjugate Vaccine and 7-Valent Pneumococcal Conjugate Vaccine: Data from the Vaccine Advere Event Reporting System (Vaers).” 2011. Thesis, Georgia State University. Accessed June 17, 2019. https://scholarworks.gsu.edu/iph_theses/159.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Arana, Jorge E. “Comparison of Post-Licensure Safety Surveillance of 13-Valent Pneumococcal Conjugate Vaccine and 7-Valent Pneumococcal Conjugate Vaccine: Data from the Vaccine Advere Event Reporting System (Vaers).” 2011. Web. 17 Jun 2019.

Vancouver:

Arana JE. Comparison of Post-Licensure Safety Surveillance of 13-Valent Pneumococcal Conjugate Vaccine and 7-Valent Pneumococcal Conjugate Vaccine: Data from the Vaccine Advere Event Reporting System (Vaers). [Internet] [Thesis]. Georgia State University; 2011. [cited 2019 Jun 17]. Available from: https://scholarworks.gsu.edu/iph_theses/159.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Arana JE. Comparison of Post-Licensure Safety Surveillance of 13-Valent Pneumococcal Conjugate Vaccine and 7-Valent Pneumococcal Conjugate Vaccine: Data from the Vaccine Advere Event Reporting System (Vaers). [Thesis]. Georgia State University; 2011. Available from: https://scholarworks.gsu.edu/iph_theses/159

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Saskatchewan

15. Lobanova, Liubov M. Development of novel vaccine candidates for measles.

Degree: 2010, University of Saskatchewan

 Despite the availability of live attenuated measles virus vaccines, a large number of measles-associated deaths occur among infants in developing countries during the "window of… (more)

Subjects/Keywords: measles; adenovirus; vaccine formulations; immune responses; vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lobanova, L. M. (2010). Development of novel vaccine candidates for measles. (Thesis). University of Saskatchewan. Retrieved from http://hdl.handle.net/10388/etd-01042011-135829

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lobanova, Liubov M. “Development of novel vaccine candidates for measles.” 2010. Thesis, University of Saskatchewan. Accessed June 17, 2019. http://hdl.handle.net/10388/etd-01042011-135829.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lobanova, Liubov M. “Development of novel vaccine candidates for measles.” 2010. Web. 17 Jun 2019.

Vancouver:

Lobanova LM. Development of novel vaccine candidates for measles. [Internet] [Thesis]. University of Saskatchewan; 2010. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10388/etd-01042011-135829.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lobanova LM. Development of novel vaccine candidates for measles. [Thesis]. University of Saskatchewan; 2010. Available from: http://hdl.handle.net/10388/etd-01042011-135829

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Arizona

16. Rivera, Jocelyn Renee. Development and Evaluation of a Clinical Practice Guideline to Promote an Evidence-based Approach to Vaccine Hesitancy in Primary Care .

Degree: 2017, University of Arizona

 The purpose of this project is to develop a clinical practice guideline with recommendations for vaccination and vaccine hesitancy in the pediatric setting. Routine vaccinations… (more)

Subjects/Keywords: immunization; vaccination; vaccine education; vaccine hesitancy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rivera, J. R. (2017). Development and Evaluation of a Clinical Practice Guideline to Promote an Evidence-based Approach to Vaccine Hesitancy in Primary Care . (Doctoral Dissertation). University of Arizona. Retrieved from http://hdl.handle.net/10150/626638

Chicago Manual of Style (16th Edition):

Rivera, Jocelyn Renee. “Development and Evaluation of a Clinical Practice Guideline to Promote an Evidence-based Approach to Vaccine Hesitancy in Primary Care .” 2017. Doctoral Dissertation, University of Arizona. Accessed June 17, 2019. http://hdl.handle.net/10150/626638.

MLA Handbook (7th Edition):

Rivera, Jocelyn Renee. “Development and Evaluation of a Clinical Practice Guideline to Promote an Evidence-based Approach to Vaccine Hesitancy in Primary Care .” 2017. Web. 17 Jun 2019.

Vancouver:

Rivera JR. Development and Evaluation of a Clinical Practice Guideline to Promote an Evidence-based Approach to Vaccine Hesitancy in Primary Care . [Internet] [Doctoral dissertation]. University of Arizona; 2017. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10150/626638.

Council of Science Editors:

Rivera JR. Development and Evaluation of a Clinical Practice Guideline to Promote an Evidence-based Approach to Vaccine Hesitancy in Primary Care . [Doctoral Dissertation]. University of Arizona; 2017. Available from: http://hdl.handle.net/10150/626638


Texas A&M University

17. Carroll, Juliette E. Babesia microti Recombinant DNA Vaccine as a Model for Babesia bovis Prevention.

Degree: 2011, Texas A&M University

 Babesiosis is caused by a genus of tick-transmitted apicomplexan parasites with considerable economic, medical, and veterinary impact. Bovine babesiosis is an important impediment to livestock… (more)

Subjects/Keywords: Babesia spp. vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Carroll, J. E. (2011). Babesia microti Recombinant DNA Vaccine as a Model for Babesia bovis Prevention. (Thesis). Texas A&M University. Retrieved from http://hdl.handle.net/1969.1/ETD-TAMU-2009-12-7248

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Carroll, Juliette E. “Babesia microti Recombinant DNA Vaccine as a Model for Babesia bovis Prevention.” 2011. Thesis, Texas A&M University. Accessed June 17, 2019. http://hdl.handle.net/1969.1/ETD-TAMU-2009-12-7248.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Carroll, Juliette E. “Babesia microti Recombinant DNA Vaccine as a Model for Babesia bovis Prevention.” 2011. Web. 17 Jun 2019.

Vancouver:

Carroll JE. Babesia microti Recombinant DNA Vaccine as a Model for Babesia bovis Prevention. [Internet] [Thesis]. Texas A&M University; 2011. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/1969.1/ETD-TAMU-2009-12-7248.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Carroll JE. Babesia microti Recombinant DNA Vaccine as a Model for Babesia bovis Prevention. [Thesis]. Texas A&M University; 2011. Available from: http://hdl.handle.net/1969.1/ETD-TAMU-2009-12-7248

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. Deal, Cailin E. Conserved epitopes in Plasmodium falciparum and influenza A virus as targets for virus-vectored immunization.

Degree: 2014, Johns Hopkins University

 The development of vaccines against infectious diseases has been highly successful. However, while effective vaccines have been licensed against many diseases such as smallpox, polio,… (more)

Subjects/Keywords: vaccine; virus-vectors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Deal, C. E. (2014). Conserved epitopes in Plasmodium falciparum and influenza A virus as targets for virus-vectored immunization. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37971

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Deal, Cailin E. “Conserved epitopes in Plasmodium falciparum and influenza A virus as targets for virus-vectored immunization.” 2014. Thesis, Johns Hopkins University. Accessed June 17, 2019. http://jhir.library.jhu.edu/handle/1774.2/37971.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Deal, Cailin E. “Conserved epitopes in Plasmodium falciparum and influenza A virus as targets for virus-vectored immunization.” 2014. Web. 17 Jun 2019.

Vancouver:

Deal CE. Conserved epitopes in Plasmodium falciparum and influenza A virus as targets for virus-vectored immunization. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2019 Jun 17]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37971.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Deal CE. Conserved epitopes in Plasmodium falciparum and influenza A virus as targets for virus-vectored immunization. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/37971

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

19. MORAN, HANNAH. The immunmodulatory properties of chitin-derived polymers are dictated by their deacetylation patterns.

Degree: School of Biochemistry & Immunology. Discipline of Biochemistry, 2018, Trinity College Dublin

 The introduction of vaccines is regarded as one of the most successful medical interventions to date, due to their effectiveness at combating diseases that require… (more)

Subjects/Keywords: vaccine; adjuvant; chitosan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

MORAN, H. (2018). The immunmodulatory properties of chitin-derived polymers are dictated by their deacetylation patterns. (Thesis). Trinity College Dublin. Retrieved from http://hdl.handle.net/2262/82147

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

MORAN, HANNAH. “The immunmodulatory properties of chitin-derived polymers are dictated by their deacetylation patterns.” 2018. Thesis, Trinity College Dublin. Accessed June 17, 2019. http://hdl.handle.net/2262/82147.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

MORAN, HANNAH. “The immunmodulatory properties of chitin-derived polymers are dictated by their deacetylation patterns.” 2018. Web. 17 Jun 2019.

Vancouver:

MORAN H. The immunmodulatory properties of chitin-derived polymers are dictated by their deacetylation patterns. [Internet] [Thesis]. Trinity College Dublin; 2018. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/2262/82147.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

MORAN H. The immunmodulatory properties of chitin-derived polymers are dictated by their deacetylation patterns. [Thesis]. Trinity College Dublin; 2018. Available from: http://hdl.handle.net/2262/82147

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

20. Pusic, Kae Myriam. Immunological investigations to re-engineer a Plasmodium falciparum blood-stage human malaria vaccine.

Degree: 2016, University of Hawaii – Manoa

Ph.D. University of Hawaii at Manoa 2012.

Despite decades of intensive research, malaria remains one of the most prevalent and devastating infectious diseases in the… (more)

Subjects/Keywords: malaria; vaccine; adjuvant

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pusic, K. M. (2016). Immunological investigations to re-engineer a Plasmodium falciparum blood-stage human malaria vaccine. (Thesis). University of Hawaii – Manoa. Retrieved from http://hdl.handle.net/10125/101525

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Pusic, Kae Myriam. “Immunological investigations to re-engineer a Plasmodium falciparum blood-stage human malaria vaccine.” 2016. Thesis, University of Hawaii – Manoa. Accessed June 17, 2019. http://hdl.handle.net/10125/101525.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Pusic, Kae Myriam. “Immunological investigations to re-engineer a Plasmodium falciparum blood-stage human malaria vaccine.” 2016. Web. 17 Jun 2019.

Vancouver:

Pusic KM. Immunological investigations to re-engineer a Plasmodium falciparum blood-stage human malaria vaccine. [Internet] [Thesis]. University of Hawaii – Manoa; 2016. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10125/101525.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Pusic KM. Immunological investigations to re-engineer a Plasmodium falciparum blood-stage human malaria vaccine. [Thesis]. University of Hawaii – Manoa; 2016. Available from: http://hdl.handle.net/10125/101525

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Oregon State University

21. Sloat, Brian R. Rational vaccine development 1) Design of a Triantigen Nasal Anthrax Vaccine Candidate 2) A Novel Lecithin Based Nanoparticle as a Vaccine Delivery System.

Degree: PhD, Pharmacy, 2010, Oregon State University

 Currently, the only anthrax vaccine licensed for human use in the United States is the Anthrax-vaccine-absorbed (AVA or Biothrax®). AVA suffers from several drawbacks, including… (more)

Subjects/Keywords: vaccine; Anthrax  – Vaccination

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sloat, B. R. (2010). Rational vaccine development 1) Design of a Triantigen Nasal Anthrax Vaccine Candidate 2) A Novel Lecithin Based Nanoparticle as a Vaccine Delivery System. (Doctoral Dissertation). Oregon State University. Retrieved from http://hdl.handle.net/1957/15311

Chicago Manual of Style (16th Edition):

Sloat, Brian R. “Rational vaccine development 1) Design of a Triantigen Nasal Anthrax Vaccine Candidate 2) A Novel Lecithin Based Nanoparticle as a Vaccine Delivery System.” 2010. Doctoral Dissertation, Oregon State University. Accessed June 17, 2019. http://hdl.handle.net/1957/15311.

MLA Handbook (7th Edition):

Sloat, Brian R. “Rational vaccine development 1) Design of a Triantigen Nasal Anthrax Vaccine Candidate 2) A Novel Lecithin Based Nanoparticle as a Vaccine Delivery System.” 2010. Web. 17 Jun 2019.

Vancouver:

Sloat BR. Rational vaccine development 1) Design of a Triantigen Nasal Anthrax Vaccine Candidate 2) A Novel Lecithin Based Nanoparticle as a Vaccine Delivery System. [Internet] [Doctoral dissertation]. Oregon State University; 2010. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/1957/15311.

Council of Science Editors:

Sloat BR. Rational vaccine development 1) Design of a Triantigen Nasal Anthrax Vaccine Candidate 2) A Novel Lecithin Based Nanoparticle as a Vaccine Delivery System. [Doctoral Dissertation]. Oregon State University; 2010. Available from: http://hdl.handle.net/1957/15311


Victoria University of Wellington

22. Hunn, Martin Kent. Improving immunotherapy for high grade glioma.

Degree: 2015, Victoria University of Wellington

 Glioblastoma multiforme (GBM) is a malignant primary brain tumour that is almost always fatal. Conventional treatment modalities are limited by toxicity. T cell-based immunotherapy is… (more)

Subjects/Keywords: Glioma; Immunotherapy; Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hunn, M. K. (2015). Improving immunotherapy for high grade glioma. (Doctoral Dissertation). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/4869

Chicago Manual of Style (16th Edition):

Hunn, Martin Kent. “Improving immunotherapy for high grade glioma.” 2015. Doctoral Dissertation, Victoria University of Wellington. Accessed June 17, 2019. http://hdl.handle.net/10063/4869.

MLA Handbook (7th Edition):

Hunn, Martin Kent. “Improving immunotherapy for high grade glioma.” 2015. Web. 17 Jun 2019.

Vancouver:

Hunn MK. Improving immunotherapy for high grade glioma. [Internet] [Doctoral dissertation]. Victoria University of Wellington; 2015. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10063/4869.

Council of Science Editors:

Hunn MK. Improving immunotherapy for high grade glioma. [Doctoral Dissertation]. Victoria University of Wellington; 2015. Available from: http://hdl.handle.net/10063/4869


Kansas State University

23. Engels, Justin Allen. Bovine salmonellosis and the challenge of developing cross protective vaccines for this disease.

Degree: MSin Biomedical Sciences, Department of Diagnostic Medicine/Pathobiology, 2017, Kansas State University

 Salmonella contamination of meat is a leading cause of foodborne illness around the world. Nontyphoidal Salmonella are responsible for an estimated 94 million infections and… (more)

Subjects/Keywords: Salmonella; Bovine; Vaccine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Engels, J. A. (2017). Bovine salmonellosis and the challenge of developing cross protective vaccines for this disease. (Masters Thesis). Kansas State University. Retrieved from http://hdl.handle.net/2097/36229

Chicago Manual of Style (16th Edition):

Engels, Justin Allen. “Bovine salmonellosis and the challenge of developing cross protective vaccines for this disease.” 2017. Masters Thesis, Kansas State University. Accessed June 17, 2019. http://hdl.handle.net/2097/36229.

MLA Handbook (7th Edition):

Engels, Justin Allen. “Bovine salmonellosis and the challenge of developing cross protective vaccines for this disease.” 2017. Web. 17 Jun 2019.

Vancouver:

Engels JA. Bovine salmonellosis and the challenge of developing cross protective vaccines for this disease. [Internet] [Masters thesis]. Kansas State University; 2017. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/2097/36229.

Council of Science Editors:

Engels JA. Bovine salmonellosis and the challenge of developing cross protective vaccines for this disease. [Masters Thesis]. Kansas State University; 2017. Available from: http://hdl.handle.net/2097/36229


Georgia Tech

24. Chang, Timothy Z. Protein nanoparticle vaccines.

Degree: PhD, Chemical and Biomolecular Engineering, 2017, Georgia Tech

 Highly conserved pathogen proteins are essential for broadly cross-protective vaccines, but tend to be poorly immunogenic. Protein nanoparticle vaccines made from conserved influenza matrix protein… (more)

Subjects/Keywords: Nanoparticle; Vaccine; Immunoengineering

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chang, T. Z. (2017). Protein nanoparticle vaccines. (Doctoral Dissertation). Georgia Tech. Retrieved from http://hdl.handle.net/1853/59778

Chicago Manual of Style (16th Edition):

Chang, Timothy Z. “Protein nanoparticle vaccines.” 2017. Doctoral Dissertation, Georgia Tech. Accessed June 17, 2019. http://hdl.handle.net/1853/59778.

MLA Handbook (7th Edition):

Chang, Timothy Z. “Protein nanoparticle vaccines.” 2017. Web. 17 Jun 2019.

Vancouver:

Chang TZ. Protein nanoparticle vaccines. [Internet] [Doctoral dissertation]. Georgia Tech; 2017. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/1853/59778.

Council of Science Editors:

Chang TZ. Protein nanoparticle vaccines. [Doctoral Dissertation]. Georgia Tech; 2017. Available from: http://hdl.handle.net/1853/59778


University of Oxford

25. Bhatnagar, Sunali. Cavitation-enhanced transdermal vaccine delivery by ultrasound.

Degree: PhD, 2014, University of Oxford

 Currently, the most common route for vaccine delivery is by intramuscular injection with a needle and syringe. Injection has number of disadvantages, such as risk… (more)

Subjects/Keywords: 614.4; Vaccine delivery

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bhatnagar, S. (2014). Cavitation-enhanced transdermal vaccine delivery by ultrasound. (Doctoral Dissertation). University of Oxford. Retrieved from https://ora.ox.ac.uk/objects/uuid:069bdaa4-a32f-4c94-9ffa-163e63c85e20 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711764

Chicago Manual of Style (16th Edition):

Bhatnagar, Sunali. “Cavitation-enhanced transdermal vaccine delivery by ultrasound.” 2014. Doctoral Dissertation, University of Oxford. Accessed June 17, 2019. https://ora.ox.ac.uk/objects/uuid:069bdaa4-a32f-4c94-9ffa-163e63c85e20 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711764.

MLA Handbook (7th Edition):

Bhatnagar, Sunali. “Cavitation-enhanced transdermal vaccine delivery by ultrasound.” 2014. Web. 17 Jun 2019.

Vancouver:

Bhatnagar S. Cavitation-enhanced transdermal vaccine delivery by ultrasound. [Internet] [Doctoral dissertation]. University of Oxford; 2014. [cited 2019 Jun 17]. Available from: https://ora.ox.ac.uk/objects/uuid:069bdaa4-a32f-4c94-9ffa-163e63c85e20 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711764.

Council of Science Editors:

Bhatnagar S. Cavitation-enhanced transdermal vaccine delivery by ultrasound. [Doctoral Dissertation]. University of Oxford; 2014. Available from: https://ora.ox.ac.uk/objects/uuid:069bdaa4-a32f-4c94-9ffa-163e63c85e20 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.711764


University of Rochester

26. Block, Olivia Kazumi Tono. Evaluation of Dengue Envelope Glycoprotein Domain III as a Subunit Vaccine Candidate for Prophylaxis of Dengue Hemorrhagic Fever/Shock Syndrome.

Degree: PhD, 2011, University of Rochester

 Antibody dependent enhancement (ADE) of dengue viral (DENV) infectivity poses a significant challenge to the development of broadly effective vaccines for the prevention of dengue… (more)

Subjects/Keywords: Dengue; Vaccine; Envelope

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Block, O. K. T. (2011). Evaluation of Dengue Envelope Glycoprotein Domain III as a Subunit Vaccine Candidate for Prophylaxis of Dengue Hemorrhagic Fever/Shock Syndrome. (Doctoral Dissertation). University of Rochester. Retrieved from http://hdl.handle.net/1802/14602

Chicago Manual of Style (16th Edition):

Block, Olivia Kazumi Tono. “Evaluation of Dengue Envelope Glycoprotein Domain III as a Subunit Vaccine Candidate for Prophylaxis of Dengue Hemorrhagic Fever/Shock Syndrome.” 2011. Doctoral Dissertation, University of Rochester. Accessed June 17, 2019. http://hdl.handle.net/1802/14602.

MLA Handbook (7th Edition):

Block, Olivia Kazumi Tono. “Evaluation of Dengue Envelope Glycoprotein Domain III as a Subunit Vaccine Candidate for Prophylaxis of Dengue Hemorrhagic Fever/Shock Syndrome.” 2011. Web. 17 Jun 2019.

Vancouver:

Block OKT. Evaluation of Dengue Envelope Glycoprotein Domain III as a Subunit Vaccine Candidate for Prophylaxis of Dengue Hemorrhagic Fever/Shock Syndrome. [Internet] [Doctoral dissertation]. University of Rochester; 2011. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/1802/14602.

Council of Science Editors:

Block OKT. Evaluation of Dengue Envelope Glycoprotein Domain III as a Subunit Vaccine Candidate for Prophylaxis of Dengue Hemorrhagic Fever/Shock Syndrome. [Doctoral Dissertation]. University of Rochester; 2011. Available from: http://hdl.handle.net/1802/14602


University of New South Wales

27. Sharpe, Sue. Immunoprophylaxis against salmonella in commercial layer chickens.

Degree: Biotechnology & Biomolecular Sciences, 2016, University of New South Wales

 Salmonellosis is one of the most common foodborne bacterial diseases globally. Salmonella does not commonly cause disease in poultry; however they are important reservoirs of… (more)

Subjects/Keywords: Vaccine; Salmonella; Poultry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sharpe, S. (2016). Immunoprophylaxis against salmonella in commercial layer chickens. (Masters Thesis). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/56953 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:42142/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Sharpe, Sue. “Immunoprophylaxis against salmonella in commercial layer chickens.” 2016. Masters Thesis, University of New South Wales. Accessed June 17, 2019. http://handle.unsw.edu.au/1959.4/56953 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:42142/SOURCE02?view=true.

MLA Handbook (7th Edition):

Sharpe, Sue. “Immunoprophylaxis against salmonella in commercial layer chickens.” 2016. Web. 17 Jun 2019.

Vancouver:

Sharpe S. Immunoprophylaxis against salmonella in commercial layer chickens. [Internet] [Masters thesis]. University of New South Wales; 2016. [cited 2019 Jun 17]. Available from: http://handle.unsw.edu.au/1959.4/56953 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:42142/SOURCE02?view=true.

Council of Science Editors:

Sharpe S. Immunoprophylaxis against salmonella in commercial layer chickens. [Masters Thesis]. University of New South Wales; 2016. Available from: http://handle.unsw.edu.au/1959.4/56953 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:42142/SOURCE02?view=true


University of Ottawa

28. Muralidharan, Abenaya. Towards Better Understanding of Respiratory Syncytial Virus (RSV) Vaccine-Induced Enhanced Disease .

Degree: 2019, University of Ottawa

At the author’s request, the abstract has been removed due to the confidential nature of the thesis. It will be added once the embargo period has passed.

Subjects/Keywords: Vaccine; RSV; Immunopathology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Muralidharan, A. (2019). Towards Better Understanding of Respiratory Syncytial Virus (RSV) Vaccine-Induced Enhanced Disease . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/39216

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Muralidharan, Abenaya. “Towards Better Understanding of Respiratory Syncytial Virus (RSV) Vaccine-Induced Enhanced Disease .” 2019. Thesis, University of Ottawa. Accessed June 17, 2019. http://hdl.handle.net/10393/39216.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Muralidharan, Abenaya. “Towards Better Understanding of Respiratory Syncytial Virus (RSV) Vaccine-Induced Enhanced Disease .” 2019. Web. 17 Jun 2019.

Vancouver:

Muralidharan A. Towards Better Understanding of Respiratory Syncytial Virus (RSV) Vaccine-Induced Enhanced Disease . [Internet] [Thesis]. University of Ottawa; 2019. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/10393/39216.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Muralidharan A. Towards Better Understanding of Respiratory Syncytial Virus (RSV) Vaccine-Induced Enhanced Disease . [Thesis]. University of Ottawa; 2019. Available from: http://hdl.handle.net/10393/39216

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

29. Jaiswal Varun. Development of Immunoinformatics Tools for Vaccine Design;.

Degree: 2014, Jaypee University of Information Technology, Solan

Though vaccines against many diseases are available but those are not effective when strain variability is very high and immune response is poor These strain… (more)

Subjects/Keywords: Adhesin; Epitope-based Vaccine Candidate; Host Pathogen Interaction; Jenner; Universal Influenza Vaccine (UIV); Vaccine Design

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Varun, J. (2014). Development of Immunoinformatics Tools for Vaccine Design;. (Thesis). Jaypee University of Information Technology, Solan. Retrieved from http://shodhganga.inflibnet.ac.in/handle/10603/26246

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Varun, Jaiswal. “Development of Immunoinformatics Tools for Vaccine Design;.” 2014. Thesis, Jaypee University of Information Technology, Solan. Accessed June 17, 2019. http://shodhganga.inflibnet.ac.in/handle/10603/26246.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Varun, Jaiswal. “Development of Immunoinformatics Tools for Vaccine Design;.” 2014. Web. 17 Jun 2019.

Vancouver:

Varun J. Development of Immunoinformatics Tools for Vaccine Design;. [Internet] [Thesis]. Jaypee University of Information Technology, Solan; 2014. [cited 2019 Jun 17]. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/26246.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Varun J. Development of Immunoinformatics Tools for Vaccine Design;. [Thesis]. Jaypee University of Information Technology, Solan; 2014. Available from: http://shodhganga.inflibnet.ac.in/handle/10603/26246

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Boston University

30. Johnson, Meredith. Motivational interviewing for vaccine hesitant parents.

Degree: MS, Physician Assistant Program, 2017, Boston University

 BACKGROUND: The widespread use of vaccines led to significant decline in multiple potentially fatal infectious diseases. Recently, there has been an increase in vaccine hesitancy.… (more)

Subjects/Keywords: Medicine; Anti-vaccine; Childhood vaccines; Immunization schedule; Motivational interviewing; Vaccine hesitancy; Vaccine hesitant parents

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Johnson, M. (2017). Motivational interviewing for vaccine hesitant parents. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/26708

Chicago Manual of Style (16th Edition):

Johnson, Meredith. “Motivational interviewing for vaccine hesitant parents.” 2017. Masters Thesis, Boston University. Accessed June 17, 2019. http://hdl.handle.net/2144/26708.

MLA Handbook (7th Edition):

Johnson, Meredith. “Motivational interviewing for vaccine hesitant parents.” 2017. Web. 17 Jun 2019.

Vancouver:

Johnson M. Motivational interviewing for vaccine hesitant parents. [Internet] [Masters thesis]. Boston University; 2017. [cited 2019 Jun 17]. Available from: http://hdl.handle.net/2144/26708.

Council of Science Editors:

Johnson M. Motivational interviewing for vaccine hesitant parents. [Masters Thesis]. Boston University; 2017. Available from: http://hdl.handle.net/2144/26708

[1] [2] [3] [4] [5] … [55]

.